Rafarma Pharmaceuticals, Inc. RAFA

Full chart Compare

Set alert

0.01 USD -0.01 (-47.06%)

At closeNov 10, 2026, 4:00 PM EST

0.009 Day range 0.01

0.004 52-week range 0.093

YTD: -66.67%
1 year: -70.00%

News

1 year ago globenewswire.com Rafarma Pharmaceuticals to Present at the Virtual Life Science Investor Forum March 13th Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as…
2 years ago globenewswire.com Rafarma pharmaceutical updates: registration of Rafarma microspheres in South Korea Sheridan, Wyoming, USA, July 04, 2024 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA) - Rafarma Pharmaceuticals is pleased to announce its participation in the scientific conference on…
2 years ago globenewswire.com Rafarma pharmaceutical updates: creation of a joint research and production enterprise in Busan (South Korea) between Rafarma and the Korean pharmaceutical company Woods Medical Care Sheridan, Wyoming, USA, July 03, 2024 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA) - Rafarma Pharmaceuticals is pleased to announce the signing of a preliminary agreement to establish a…
2 years ago globenewswire.com Rafarma pharmaceutical updates: agreements with Shri Lanka pharmaceutical company Kelun Lifesciences (Pvt) Ltd and El Salvador University Wyoming, USA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA) - We are pleased to announce that Rapharma and its CEO Raivo Unt have entered into a preliminary agreement with…
2 years ago globenewswire.com Rafarma Pharmaceutical news update Russia, Moscow, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA). The Company is pleased to announce that it has completed the restructuring, accounting and balance sheet…
5 years ago globenewswire.com Rafarma Enters Negotiations With Leading Global Producer of Precious Metals to Localize Production of Platinum-Based Cancer Drugs Nicosia, Cyprus, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) and one of the world's largest producers of precious metals, Krastsvetmet (Russia, Krasnoyarsk), discussed…
5 years ago globenewswire.com Letter to Shareholders from the Chairman of the Board Ilya Shpurov Nicosia, Cyprus, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC: (RAFA) shares the following letter to shareholders from Chairman of the Board Ilya Shpurov:
5 years ago globenewswire.com Rafarma Signs Trilateral Investment Agreement Officially Launching Tashkent Pharmaceutical Plant Build Nicosia, Cyprus, July 30, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) The scientific and technical council of the Agency for the Development of the Pharmaceutical Industry of…
5 years ago globenewswire.com Rafarma's Global Pharmaceutical Strategy At A Glance Nicosia, Cyprus, May 18, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is an international biotechnological and pharmaceutical company that combines research centers and modern…
5 years ago globenewswire.com Rafarma To Expand Proton Therapy Centers Nicosia, Cyprus, May 07, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that RAFA is in active meetings the City Scientific University of Istanbul (Turkey)…
5 years ago globenewswire.com Rafarma and Haifa Technopark Enter Talks for Joint Venture Nicosia, Cyprus, April 30, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that on April 26, 2021 the company entered negotiations and formed an action plan…
5 years ago globenewswire.com Rafarma Embarks on Aggressive Global Partnerships Plan Nicosia, Cyprus, March 04, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce its newly formulated strategies for aggressive global growth in 2021/2022. Given…